Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
WeaverCMAlexanderDDBousheyCJDawson-HughesBLappeJMLeBoffMSet al
Both drugs showed significant antitumor activity, with serum asparaginase activity (SAA) 0.1 UI/ml (considered therapeutic) in 95% of patients in both groups after 18 days of treatment and 25 days after treatment
Acetylcholinesterase inhibitors (AChEIs), such as donepezil, rivastigmine, and galantamine, are the firstline treatments for mild to moderate AD (Moreira et al
For me, DSIP became something I use a few times a year when my sleep gets off track
US$ 25.89
US$ 25.70
US$ 22.54
US$ 20.00
US$ 23.41
US$ 22.61
US$ 27.25
